GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Adjusted EPS | ₹10.53 | ₹33.37 | ₹34.38 | ₹27.50 | ₹32.78 |
What is the latest Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2024 | ₹10.53 |
Mar2023 | ₹33.37 |
Mar2022 | ₹34.38 |
Mar2021 | ₹27.50 |
Mar2020 | ₹32.78 |
How is Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2024 | ₹10.53 | -68.44 | |
Mar2023 | ₹33.37 | -2.94 | |
Mar2022 | ₹34.38 | 25.02 | |
Mar2021 | ₹27.50 | -16.11 | |
Mar2020 | ₹32.78 | - |
Compare Earnings Per Share (EPS) of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹40,810.4 Cr | 3.7% | 5% | 40.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹417,400.0 Cr | -0.3% | 3.1% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,844.0 Cr | 3.5% | 11% | 63.5% | Stock Analytics | |
CIPLA | ₹121,328.0 Cr | 1.6% | 2.7% | 11.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,521.0 Cr | 4.1% | 4.4% | 24.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,043.0 Cr | 6.8% | 11.3% | 3.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 3.7% |
5% |
40.9% |
SENSEX | 2.7% |
11.8% |
14% |
You may also like the below Video Courses